These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 26409344)

  • 21. Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson's Disease.
    Theis H; Pavese N; Rektorová I; van Eimeren T
    J Parkinsons Dis; 2024; 14(s2):S353-S365. PubMed ID: 38339941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Thobois S; Guillouet S; Broussolle E
    Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
    Gan C; Cao X; Sun H; Ye S; Shi J; Shan A; Gao M; Wan C; Zhang K; Yuan Y
    Neurobiol Dis; 2024 Aug; 198():106560. PubMed ID: 38852751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.
    Filippi M; Balestrino R; Basaia S; Agosta F
    Mov Disord; 2022 Jul; 37(7):1375-1393. PubMed ID: 35521899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroimaging in Parkinson disease: from research setting to clinical practice.
    Politis M
    Nat Rev Neurol; 2014 Dec; 10(12):708-22. PubMed ID: 25385334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on Molecular Imaging in Parkinson's Disease.
    Liu ZY; Liu FT; Zuo CT; Koprich JB; Wang J
    Neurosci Bull; 2018 Apr; 34(2):330-340. PubMed ID: 29282614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive imaging modalities to study neurodegenerative diseases of aging brain.
    Annavarapu RN; Kathi S; Vadla VK
    J Chem Neuroanat; 2019 Jan; 95():54-69. PubMed ID: 29474853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
    Christopher L; Strafella AP
    J Neuropsychol; 2013 Sep; 7(2):225-40. PubMed ID: 23551844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcranial sonography in relation to SPECT and MIBG.
    Kajimoto Y; Miwa H; Kondo T
    Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Initial diagnosis of Parkinson's disease - neuroradiological diagnosis].
    Orimo S
    Rinsho Shinkeigaku; 2013; 53(11):977-80. PubMed ID: 24291851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connectivity Between Brain Networks Dynamically Reflects Cognitive Status of Parkinson's Disease: A Longitudinal Study.
    Klobušiaková P; Mareček R; Fousek J; Výtvarová E; Rektorová I
    J Alzheimers Dis; 2019; 67(3):971-984. PubMed ID: 30776007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
    Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
    Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.
    Ray NJ; Strafella AP
    Mov Disord; 2012 Oct; 27(12):1484-92. PubMed ID: 23038645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.
    Lenka A; Jhunjhunwala KR; Saini J; Pal PK
    Parkinsonism Relat Disord; 2015 Jul; 21(7):683-91. PubMed ID: 25920541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions.
    Lauretani F; Longobucco Y; Ravazzoni G; Gallini E; Salvi M; Maggio M
    Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33670940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review.
    Al-Radaideh AM; Rababah EM
    Clin Imaging; 2016; 40(5):987-96. PubMed ID: 27288741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging advances in Parkinson's disease.
    Rispoli V; Schreglmann SR; Bhatia KP
    Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging in Parkinson's disease: a future perspective.
    Brooks DJ
    Neurodegener Dis Manag; 2015; 5(2):105-8. PubMed ID: 25894874
    [No Abstract]   [Full Text] [Related]  

  • 40. Drift in centrality of different brain regions in an anatomical neural network with Parkinson's disease: A view from complex network analysis.
    Lei X; Huang B; Li H; Jiang H; Hu X; Zhang B
    Neuroscience; 2015 Jul; 299():107-24. PubMed ID: 25937399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.